Skip to content

Clinical trials

Phase 2 Inflammatory Bowel Diseases trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammatory Bowel Diseases Phase: Phase 2 Country / region: Serbia Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20162
20172
20181
20202
20221
20243
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Terminated5
Recruiting3
Active, not recruiting1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company)2
Protagonist Therapeutics, Inc.2
Spyre Therapeutics, Inc.2
Arena Pharmaceuticals1
Eli Lilly and Company1
GB004, Inc.1
Genentech, Inc.1
InDex Pharmaceuticals1
Kyowa Kirin, Inc.1
Palisade Bio1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammatory Bowel Diseases15
Colitis, Ulcerative10
Colitis6
Gastrointestinal Diseases4
Crohn Disease3
Colonic Diseases2
Digestive System Diseases2
Intestinal Diseases2
Abdominal Pain1
Autoimmune Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.